Suvretta Capital Management »

Horizon Therapeutics shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Horizon Therapeutics shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Horizon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Horizon Therapeutics held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Horizon Therapeutics by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $91M 786k 115.69
2023-06-30 $82M 793k 102.85
2023-03-31 $106M 974k 109.14
2022-12-31 $100M 874k 113.80
2022-09-30 $44M 713k 61.89
2022-06-30 $39M 487k 79.76

More positions owned by Suvretta Capital Management

Royalty Pharma Shs Class A (RPRX)
Biohaven (BHVN)
Arcellx Common Stock (ACLX)
Horizon Therapeutics Pub L SHS
Insmed Com Par $.01 (INSM)
Meta Platforms Cl A (META)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Intra Cellular Therapies (ITCI)
Microsoft Corporation (MSFT)
Kura Oncology (KURA)
Wynn Resorts (WYNN)
Marinus Pharmaceuticals Com New (MRNS)
89bio (ETNB)
General Electric Com New (GE)

View all positions for Suvretta Capital Management

Top funds holding Horizon Therapeutics

IFP Advisors
Ronald Blue Trust
Beacon Capital Management
Huntington National Bank

View all funds holding Horizon Therapeutics